HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interferon response heterogeneity: activation of a pro-inflammatory response by interferon alpha and beta. A possible basis for diverse responses to interferon beta in MS.

Abstract
Interferon gamma (IFN-gamma) stimulates the (pro-inflammatory) type II interferon receptor and is known to exacerbate multiple sclerosis (MS). In contrast, IFN-alpha and IFN-beta are ligands for the (anti-inflammatory) type I interferon receptor and are beneficial in some (but not all) patients with MS. Should IFN-beta elicit a type-II-like pro-inflammatory response, the beneficial effects might be attenuated. These studies were undertaken to test this possibility with the use of quinolinic acid (QUIN) formation as a measure of type II receptor activation. In normal human macrophage cultures, IFN-gamma was the most potent stimulus for QUIN formation. Generally, IFN-beta and IFN-alpha were less potent. However, an unexpected inter-patient variability was observed. In some subjects, IFN-alpha was more potent than IFN-beta. In other subjects, IFN-beta was more potent than IFN-alpha. The present data demonstrate an inter-subject variability for QUIN production following exposure to the interferons. MS patients who demonstrate a pro-inflammatory response to IFN-beta (e.g., increased QUIN) may be less likely to benefit from this therapy.
AuthorsM Jansen, J F Reinhard Jr
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 65 Issue 4 Pg. 439-43 (Apr 1999) ISSN: 0741-5400 [Print] United States
PMID10204571 (Publication Type: Journal Article)
Chemical References
  • Interferon-alpha
  • Interferon-beta
  • Interferon-gamma
Topics
  • Adult
  • Cells, Cultured
  • Female
  • Humans
  • Inflammation (immunology)
  • Interferon-alpha (immunology, pharmacology)
  • Interferon-beta (immunology, pharmacology)
  • Interferon-gamma (immunology, pharmacology)
  • Macrophages
  • Male
  • Monocytes
  • Multiple Sclerosis (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: